The board of directors of Rici Healthcare Holdings Limited announced that in accordance with the articles of association of the company, the Board has resolved that Ms. Cai Di and Mr. Lin Hefei have been appointed as vice presidents of the company with a term of office from January 20, 2017 to January 19, 2018. As the chief financial officer and a vice president of the company, Ms. Cai will be responsible for managing the company s financial operations, investor relationship, compliance and Board office matters. Ms. Cai has been the chief financial officer of the company since February 2015 and a vice president of the company since January 2017. Prior to joining the company, Ms. Cai was an audit manager of Ernst & Young Hua Ming LLP Shanghai Branch from October 2000 to June 2008, responsible for matters relating to auditing and tax consulting. From June 2008 to March 2013, Ms. Cai was the chief financial officer of Shanghai Newsummit Biopharma Research Co. Ltd. Mr. Lin will be responsible for the overall management of the medical examination department of the company. Mr. Lin has been the deputy general manager of the medical examination department of the company since July 2012 and a vice president of the company since January 2017. Prior to joining the company, Mr. Lin was a vice president of Jiangsu Tayoi Cosmetics Co. Ltd. The Board further announced that with effect from January 20, 2017, Mr. Shao Zhong resigned as the board secretary of the company due to his intended pursuit of other personal business engagement. The company will not set the position of board secretary in the future and the duties of Mr. Shao have been handed over to relevant staff of the company including Ms. Cai. The resignation of Mr. Shao will not affect the daily operation of the company.